SCHEMBL19845501

SCHEMBL19845501

c1ccc(-c2cc(-c3ccccc3)cc(-c3cccc(-c4nc(-c5cccc(-n6c7ccccc7c7cc(-c8ccc9oc%10ccccc%10c9c8)ccc76)c5)nc(-n5c6ccccc6c6cc(-c7ccc8oc9ccccc9c8c7)ccc65)n4)c3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
PLA2G10 O15496 1/20 0.37
CHEK2 O96017 1/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ATM Q13315 1/20 0.35
HPSE Q9Y251 2/20 0.33
PRKDC P78527 1/20 0.33
PTGER4 P35408 1/20 0.33
TSPO P30536 1/20 0.32
PGR P06401 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19845504 0.99 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL20634227 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL23318012 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL19845454 0.97 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL23317950 0.96 KDM4E (0.39) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL18566013 0.96 CHEK2 (0.36) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL19845459 0.96 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL19845718 0.95 KDM4E (0.38) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL24302119 0.95 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL18566014 0.95 CHEK2 (0.36) PLA2G2APLA2G4APLA2G10CHEK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 US disclosed
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE PIEZO1, ETV6, LEF1 PLA2G2A 3600/4885PLA2G4A 4218/4885PLA2G10 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.